Effect of Apixaban on Clinical Outcomes in Outpatients With COVID-19: The APOLLO Randomized Clinical Trial.
Publication
, Journal Article
de Barros E Silva, PGM; Macedo, AVS; Bronhara, B; Damiani, LP; Mazza Barbosa, L; Lopes, NR; Suiama, MA; Antunes, MO; Gonçalves, MR; Gebara, OCE ...
Published in: Circulation
July 2, 2024
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
July 2, 2024
Volume
150
Issue
1
Start / End Page
82 / 85
Location
United States
Related Subject Headings
- Treatment Outcome
- SARS-CoV-2
- Pyridones
- Pyrazoles
- Outpatients
- Middle Aged
- Male
- Humans
- Female
- Factor Xa Inhibitors
Citation
APA
Chicago
ICMJE
MLA
NLM
de Barros E Silva, P. G. M., Macedo, A. V. S., Bronhara, B., Damiani, L. P., Mazza Barbosa, L., Lopes, N. R., … Coalition COVID-19 Brazil Investigators. (2024). Effect of Apixaban on Clinical Outcomes in Outpatients With COVID-19: The APOLLO Randomized Clinical Trial. Circulation, 150(1), 82–85. https://doi.org/10.1161/CIRCULATIONAHA.123.066709
Barros E Silva, Pedro Gabriel Melo de, Ariane Vieira Scarlatelli Macedo, Bruna Bronhara, Lucas Petri Damiani, Lilian Mazza Barbosa, Nathália Rodrigues Lopes, Mayra Akimi Suiama, et al. “Effect of Apixaban on Clinical Outcomes in Outpatients With COVID-19: The APOLLO Randomized Clinical Trial.” Circulation 150, no. 1 (July 2, 2024): 82–85. https://doi.org/10.1161/CIRCULATIONAHA.123.066709.
de Barros E Silva PGM, Macedo AVS, Bronhara B, Damiani LP, Mazza Barbosa L, Lopes NR, et al. Effect of Apixaban on Clinical Outcomes in Outpatients With COVID-19: The APOLLO Randomized Clinical Trial. Circulation. 2024 Jul 2;150(1):82–5.
de Barros E Silva, Pedro Gabriel Melo, et al. “Effect of Apixaban on Clinical Outcomes in Outpatients With COVID-19: The APOLLO Randomized Clinical Trial.” Circulation, vol. 150, no. 1, July 2024, pp. 82–85. Pubmed, doi:10.1161/CIRCULATIONAHA.123.066709.
de Barros E Silva PGM, Macedo AVS, Bronhara B, Damiani LP, Mazza Barbosa L, Lopes NR, Suiama MA, Antunes MO, Gonçalves MR, Gebara OCE, de Aquino Martins P, Ribeiro MG, de Moura Xavier de Moraes JB, Aguiar VCR, Cavalcanti AB, Rosa RG, Berwanger O, Veiga VC, Azevedo LCP, Ramacciotti E, Granger CB, Alexander JH, Avezum A, Lopes RD, Coalition COVID-19 Brazil Investigators. Effect of Apixaban on Clinical Outcomes in Outpatients With COVID-19: The APOLLO Randomized Clinical Trial. Circulation. 2024 Jul 2;150(1):82–85.
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
July 2, 2024
Volume
150
Issue
1
Start / End Page
82 / 85
Location
United States
Related Subject Headings
- Treatment Outcome
- SARS-CoV-2
- Pyridones
- Pyrazoles
- Outpatients
- Middle Aged
- Male
- Humans
- Female
- Factor Xa Inhibitors